Nymox Pharmaceutical
NYMX
#10186
Rank
NZ$31.5 M
Marketcap
Country
NZ$0.35
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Nymox Pharmaceutical (NYMX)

Market cap: NZ$31.5 Million

As of December 2025 Nymox Pharmaceutical has a market cap of NZ$31.5 Million. This makes Nymox Pharmaceutical the world's 10186th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Nymox Pharmaceutical from 1997 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$31.5 M-2.67%
2024NZ$32.36 M12.13%
2023NZ$28.86 M-37.38%
2022NZ$46.09 M-71.44%
2021NZ$0.16 B-39.19%
2020NZ$0.26 B14.07%
2019NZ$0.23 B84.18%
2018NZ$0.12 B-50.03%
2017NZ$0.25 B36.98%
2016NZ$0.18 B-10.43%
2015NZ$0.20 B1024.95%
2014NZ$18.31 M-92.85%
2013NZ$0.25 B-8.52%
2012NZ$0.27 B-18.85%
2011NZ$0.34 B16.06%
2010NZ$0.29 B51.34%
2009NZ$0.19 B11.08%
2008NZ$0.17 B-19.93%
2007NZ$0.22 B61.55%
2006NZ$0.13 B66.44%
2005NZ$82.12 M-18.23%
2004NZ$0.10 B-20.84%
2003NZ$0.12 B-16.4%
2002NZ$0.15 B-27.53%
2001NZ$0.20 B148.06%
2000NZ$84.42 M-19.8%
1999NZ$0.10 B-43.76%
1998NZ$0.18 B-13.64%
1997NZ$0.21 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
NZ$368.10 B 1,168,436.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$252.96 B 802,931.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$34.64 B 109,873.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.537 T 4,879,942.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$858.78 B 2,726,110.48%๐Ÿ‡บ๐Ÿ‡ธ USA